Omeros Stock (NASDAQ: OMER) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 336.44K |
Day Range | - - - |
52 Wk Range | 0.92 - 5.68 |
Market Cap | $218.46M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 20.9% |
Days to Cover | 49.7 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Omeros (NASDAQ:OMER) through any online brokerage.
Other companies in Omeros’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS) and Esperion Therapeutics (NASDAQ:ESPR).
Omeros has a consensus price target of $5.25.
The stock price for Omeros (NASDAQ: OMER) is $3.77 last updated September 23, 2024 at 4:01 PM EDT.
There are no upcoming dividends for Omeros.
Omeros’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Omeros.
Omeros is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.